Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
Referred to the House Committee on Education and Workforce.
Original title: “HR 9952: Healthy Access for Learning Act”
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4477-4478)
Original title: “S 5250: A bill to amend title XVIII of the Social Security Act to decrease fraud related to home health agencies in Medicare, and for other purposes.”
Placed on Senate Legislative Calendar under General Orders. Calendar No. 538.
Original title: “S 3097: Health Information Privacy Reform Act”
The ACF, ORR announces the intent to award a single-source cooperative agreement in an amount of up to $150,000,000 to Burke Law Group, a law firm headquartered in Houston, Texas. The purpose of this proposed award is to provide legal orientation, legal consultation, and attorney-of-record representation services for eligible unaccompanied alien children (UACs) during immigration proceedings before the Executive Office for Immigration Review (EOIR) and in hearings and proceedings before the U.S.
Original title: “Announcement of the Intent To Award a Single-Source Cooperative Agreement to Burke Law Group, PLLC in Houston, Texas”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Original title: “S 5295: NIH Mentorship Modernization Act”
Read twice and referred to the Committee on Finance.
Original title: “S 5297: American Pharmaceutical Security Act”
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry (GFI) #152 entitled "Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to their Microbiological Effects on Bacteria of Human Health Concern." This guidance document informs interested parties about FDA's current method for evaluating potential microbiological effects of antimicrobial new animal drugs on bacteria of human health concern as part of the new animal
Original title: “Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to their Microbiological Effects on Bacteria of Human Health Concern; Guidance for Industry; Availability”
Read twice and referred to the Committee on Finance.
Original title: “S 5326: Health Care Fraud Prevention and Enforcement Act”
The Food and Drug Administration (FDA) is classifying the fludeoxyglucose F18-guided radiation therapy system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the fludeoxyglucose F18-guided radiation therapy system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiven
Original title: “Medical Devices; Radiology Devices; Classification of the Fludeoxyglucose F18-Guided Radiation Therapy System”
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Original title: “HR 10056: To amend title XVIII of the Social Security Act to provide for patient protection by limiting the number of mandatory overtime hours a nurse may be required to work in certain providers of services to which payments are made under the Medicare Program.”
Referred to the House Committee on Energy and Commerce.
Original title: “HR 10068: To amend the Public Health Service Act to provide for a Reducing Youth Use of E-Cigarettes Initiative.”
Read twice and referred to the Committee on Finance.
Original title: “S 5319: Nurse Overtime and Patient Safety Act”
Read twice and referred to the Committee on Veterans' Affairs.
Original title: “S 5334: A bill to designate the community-based outpatient clinic of the Department of Veterans Affairs in Lubbock, Texas, as the "Lieutenant General Bernie Mittemeyer VA Clinic".”
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled HIV Capacity Building Assistance (CBA) Program: Data Management, Monitoring, and Evalu
Original title: “Proposed Data Collection Submitted for Public Comment and Recommendations”
Read twice and referred to the Committee on Finance.
Original title: “S 5296: Pathways to Health Careers Act”
Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”
Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”
Original title: “Agency Forms Undergoing Paperwork Reduction Act Review”
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Original title: “Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)”